In vivo evaluation of bioactive glass foams associated with platelet-rich plasma in bone defects

Journal of Tissue Engineering and Regenerative Medicine

Volumn 2, Issue 4, 2008, Pages 221-227

  Dutra, Carlos E A ^a   Pereira, Marivalda M ^a   Serakides, Rogéria ^a   Rezende, Cleuza M F ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Bioactive glass foam; Biomaterials; Bone; Osteoconduction; Sol gel

Indexed keywords

BIOACTIVE GLASS; DEFECTS; PLASMA (HUMAN); PLATELETS; SOL-GEL PROCESS; SOL-GELS;

BIOACTIVE GLASS FOAMS; BONE AREA; BONE DEFECT; BONE FORMATION; CONTROL GROUPS; IN-VIVO; OSTEOCONDUCTION; PLATELET RICH PLASMA; SOL'GEL; SOL- GEL METHODS;

BONE;

BIOMATERIAL; GLASS;

ALVEOLAR BONE; ALVEOLAR RIDGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE BIOPSY; BONE DEFECT; BONE MATURATION; BONE REGENERATION; CONTROLLED STUDY; FOAM; HISTOLOGY; MALE; NONHUMAN; OSSIFICATION; PREMOLAR TOOTH; PRIORITY JOURNAL; THROMBOCYTE RICH PLASMA; TOOTH EXTRACTION; ANIMAL; BONE DEVELOPMENT; BONE DISEASE; DOG; EVALUATION; INSTRUMENTATION; JAW; MATERIALS TESTING; METABOLISM; PATHOLOGY; PHYSIOLOGY; POROSITY; PROSTHESES AND ORTHOSES; SCANNING ELECTRON MICROSCOPY; TISSUE ENGINEERING;

ALVEOLAR PROCESS; ANIMALS; BONE DISEASES; BONE REGENERATION; DOGS; GLASS; MALE; MATERIALS TESTING; MICROSCOPY, ELECTRON, SCANNING; OSTEOGENESIS; PLATELET-RICH PLASMA; POROSITY; PROSTHESES AND IMPLANTS; TISSUE ENGINEERING;

EID: 52449089932     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.86     Document Type: Article

References (27)

1. Bartley PM, Martinez NA. 2001; Metabolismo del hueso periodontal. Rev ADM 5(V.XLIX): 283-88.
2. Bell E. 1997; Organotypic and histotypic models. In Principles of Tissue Engineering, Lanza PR, Langer R, Chick LW (eds). R. G. Landres and Academic Press: New York, TX; 181-191.
3. Choi BH, Zhu SJ, Kim BY, et al. 2004; Effect of platelet-rich plasma (PRP) concentration on the viability and proliferation of alveolar bone cells: an in vitro study. Int J Oral Maxillofac Surg 34: 420-424.
4. Coelho MB, Pereira MM. 2005; Sol-gel synthesis of bioactive glass scaffolds for tissue engineering: effect of surfactant type and concentration. J Biomed Mater Res B Appl Biomater 75B(2): 451-456.
5. Cunningham N, Reddi AH. 1992; Biologic principles of bone induction. In Bone Grafts and Bone Substitutes, Habal MB, Reddi AH (eds). Saunders: Philadelphia, PA: 93-98.
6. Dugrillon A, Eichler H, Kern S, et al. 2002; Autologous concentrated platelet-rich plasma (PRP) for local application in bone regeneration. Int J Oral Maxillofac Surg 31: 615-619.
7. Froum SJ, Wallace SS, Tarnow DP, et al. 2002; Effect of platelet rich plasma on bone grow and osteoinegration in human maxillary sinus grafts: three bilateral case reports. Int J Periodont Restor Dent 22: 45-53.
8. Gough JE, Jones JR, Hench LL. 2004; Nodule formation and mineralization of human primary osteoblasts cultured on a porous bioactive glass scaffold. Biomaterials 25: 2039-2046.
9. Grennspan DC, Zhong JP, Wheller DL. 1998; Bioactivity and biodegrability: melt vs. sol-gel derived bioglass in vitro and in vivo. Proceedings of the 11th International Symposium on Ceramics in Medicine: Bioceramics. World Scientific: New York: 345-349.
10. Hammadouche M, Meunier A, Grennspan DC. 2001; Long-term in vivo bioactivity and degradability of bulk sol-gel bioactive glasses. J Biomed Mater Res 4: 560-566.
11. Hench LL. 1997; Sol-gel materials for bioceramic applications. Current Opin Solid State Mater Sci 2: 604-610.
12. Hench LL. 1998; Bioceramics. J Am Ceramic Soc 81: 1705-1728.
13. Jones JR, Hench LL. 2003; Regeneration of trabecular bone using porous ceramics. Curr Opin Solid State Mater Sci 7: 301-307.
14. Jones JR, Ehrenfried LM, Hench LL. 2006; Optimising bioactive glass scaffolds for tissue engineering. Biomaterials 27: 964-973.
15. Langer R. 1997; Tissue engineering: a new field and its challenges. Pharm Res 14: 840-841.
16. Leonetti JA, Rambo HM, Throdson RR. 2000; Osteotome sinus elevation and implant placemant with narrow size bioactive glass. Implant Dent 9(2): 177-182.
17. Lynch SE. 1994; The role of growth factors in periodontal repair and regeneration. In Periodontal Regeneration. Current Status and Directions, Polson AM (1ed). Quintessence, Chicago, IL, 221 p.
18. Marx RE, Carlson ER, Eishtaed RM. 1998; Platelet-rich plasma: growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol 85: 638-646.
19. Nevins ML, et al. 2000; Human histologic evaluation of bioactive ceramic in the treatment of periodontal osseous defect. Int J Periodontics Restor Dent 20(5): 458-467.
20. Pereira MM. 1994; Bioactive Gel Glasses: Processing and Reacting Mechanisms. PhD Thesis, Graduate School of the University of Florida.
21. Putnam JA, Mooney JD. 1996; Tissue engineering using synthetic extracelular matrices. Nat Med 7: 824-826.
22. Radin S. 2005; In vivo tissue response to a reabsorbable silica xerogel as controlled-release material. Biomaterials 26: 1043-1052.
23. Sepulveda P, Jones JR, Hench LL. 2002; Bioactive sol-gel foams for tissue repair. J Biomed Mater Res 59(2): 340-348.
24. Tadjedim ES, et al. 2000; Histological observations on biopsies harvested following sinus floor elevation using a bioactive glass material of narrow size range. Clin Oral Implants Res 11(4): 334-344.
25. Urist MR. 1972; Osteoinduction in undermineralized bone implants modified by chemical inhibitors of endogenous matrix enzymes. Clin Orthop 78: 132.
26. Xinus ID, et al. 2000; Ionic products of bioactive glass dissolution increase proliferation of human osteoblasts and induce insulin growth factor II mRNA expression and protein synthesis. Biochem Biophys Res Commun 276: 461-465.
27. Yang Z, et al. 1996; Osteogenesis in extraskeletally implanted porous calcium. Phosphate ceramics: variability among different kinds of animals. Biomaterials 17: 2131-2137.